8-K
Current Report
C4 Therapeutics, Inc. Filed Acc 0001628280-26-024583
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading cccc-20260410.htm…